Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
890.20    7.00 (0.79%)
Bid:
889.60
Ask:
890.20
Spread: 0.60 (0.067%)
Market Cap: £8.02b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

SHARE BUYBACK PROGRAMME

15 May 2025 07:00

RNS Number : 7298I
Sage Group PLC (The)
15 May 2025
 

THE SAGE GROUP PLC

SHARE BUYBACK PROGRAMME

 

Sage announces that it is extending its ongoing share buyback programme by up to £200 million.

London 15 May 2025 - The Sage Group plc ("Sage" or the "Group") today announces a share buyback programme extension for aggregate consideration of up to £200 million (the "Extended Programme") which will commence on completion of its ongoing share buyback programme for aggregate consideration of up to £400 million announced on 20 November 2024 (the "Initial Programme").

The Initial Programme is expected to end no later than 3 June 2025 (as previously announced) and, following its completion, the Extended Programme will commence. The Extended Programme is expected to end no later than 6 August 2025.

The Extended Programme is consistent with the Group's disciplined capital allocation policy, and reflects the Board's confidence in Sage's future prospects, together with Sage's strong cash generation and robust financial position. Sage continues to have considerable financial flexibility to drive the execution of its growth strategy.

Further details of the Extended Programme are set out below.

________________________________________

Enquiries

The Sage Group plc: +44 (0) 7341 479956

Caroline Xu, Group Finance

James Sandford, Investor Relations

David Ginivan, Corporate PR

FGS Global: +44 (0) 20 7251 3801

Conor McClafferty

Sophia Johnston

________________________________________

Further details of the Extended Programme

Sage has entered into non-discretionary arrangements with Morgan Stanley & Co. International plc ("Morgan Stanley") and J.P. Morgan Securities plc ("J.P. Morgan") (together, the "Brokers") in relation to the purchase by the Brokers, acting as riskless principals, of ordinary shares of Sage (the "Shares"). Morgan Stanley will conduct the first half of the Extended Programme and J.P. Morgan will conduct the second half. The Extended Programme will commence on the trading day after the Initial Programme is completed and, in any case, no later than 4 June 2025.

The Brokers will make trading decisions in relation to Shares purchased under the Extended Programme independently of, and uninfluenced by, Sage. The purpose of the Extended Programme is to reduce the share capital of Sage. The Brokers will make an on-sale of such Shares to Sage and all Shares repurchased will be cancelled.

Any purchases of Shares contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s) and will be effected within certain pre-set parameters. These arrangements are in accordance with Sage's general authority to repurchase Shares granted at its latest Annual General Meeting, Chapter 9 of the UK Listing Rules, and those provisions of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buyback programmes.

The maximum number of Shares which may currently be purchased or committed to be purchased by Sage under the Extended Programme is 81,555,354, which is the maximum number remaining as of the date of this announcement pursuant to the relevant authorities granted by shareholders at Sage's latest Annual General Meeting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFDFALEISEDI
Date   Source Headline
15th Dec 20202:10 pmRNSDirector/PDMR Shareholding
10th Dec 20205:04 pmRNSNotice of AGM
9th Dec 20207:00 amRNSDisposal of Polish Business
8th Dec 20206:15 pmRNSDirector/PDMR Shareholding
8th Dec 20207:00 amRNSDirector/PDMR Shareholding
4th Dec 20206:24 pmRNSDirector/PDMR Shareholding
3rd Dec 20206:19 pmRNSDirector/PDMR Shareholding
2nd Dec 20203:19 pmRNSAnnual Financial Report
30th Nov 20201:57 pmRNSTotal Voting Rights
24th Nov 202011:34 amRNSDirector/PDMR Shareholding
20th Nov 20204:54 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSFinal Results
30th Oct 202012:32 pmRNSTotal Voting Rights
20th Oct 20204:35 pmRNSHolding(s) in Company
30th Sep 20204:16 pmRNSTotal Voting Rights
16th Sep 20209:49 amRNSDirector/PDMR Shareholding
9th Sep 20201:25 pmRNSDirector/PDMR Shareholding
8th Sep 20204:08 pmRNSDirector/PDMR Shareholding
28th Aug 20205:04 pmRNSTotal Voting Rights
27th Aug 20207:00 amRNSChairman Retirement
14th Aug 20205:23 pmRNSDirector/PDMR Shareholding
13th Aug 202012:20 pmRNSDirector/PDMR Shareholding
6th Aug 20202:29 pmRNSHolding(s) in Company
5th Aug 20207:00 amRNSDirector/PDMR Shareholding
31st Jul 20202:27 pmRNSTotal Voting Rights
23rd Jul 20207:00 amRNSTrading Update
30th Jun 20204:36 pmRNSTotal Voting Rights
30th Jun 20207:00 amRNSDirectorate Change
25th Jun 20202:12 pmRNSDirector/PDMR Shareholding
12th Jun 202011:46 amRNSDirector/PDMR Shareholding
10th Jun 202010:01 amRNSDirector/PDMR Shareholding
8th Jun 20202:02 pmRNSBlock listing Interim Review
29th May 20204:13 pmRNSTotal Voting Rights
21st May 20205:26 pmRNSDirector/PDMR Shareholding
13th May 20207:00 amRNSHalf-year Report
30th Apr 20205:54 pmRNSTotal Voting Rights
27th Apr 20205:58 pmRNSPublication of Articles of Association
23rd Apr 20207:00 amRNSDirector Declaration
7th Apr 20203:00 pmRNSDisclosure under S. 430(2B) Companies Act 2006
6th Apr 20207:00 amRNSTrading and COVID-19 Update
1st Apr 20207:15 amRNSSage completes disposal of Brazilian Business
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20201:47 pmRNSSuspension of share buy-back programme
17th Mar 20206:09 pmRNSTransaction in Own Shares
16th Mar 20206:23 pmRNSTransaction in Own Shares
13th Mar 20205:25 pmRNSTransaction in Own Shares
12th Mar 20206:18 pmRNSTransaction in Own Shares
12th Mar 20207:00 amRNSShare buy-back programme
11th Mar 20203:11 pmRNSSage completes disposal, announces share buy-back
9th Mar 202010:06 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.